Gene · 965
Papers4,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 4,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neuroimmune circuits in respiratory pathophysiology: decoding molecular crosstalk for precision therapeutic targeting. | Ann Med | 2026 | 41601146 | PubTator, text mining | PubMed |
| Immune synapse molecules knockout in induced pluripotent stem cells enables broad NK cell resistance in T cell progeny. | Regen Ther | 2026 | 41585043 | PubTator, text mining | PubMed |
| CD2 costimulation bridges potent CAR-induced cytolysis and durable persistence. | J Immunother Cancer | 2026 | 41571300 | PubTator, text mining | PubMed |
| Biological heterogeneity in adult IRF4-rearranged large B-cell lymphoma: Stratification by age and anatomical site. | Hemasphere | 2026 | 41560848 | PubTator, text mining | PubMed |
| A case report and a literature review of Myeloid/Lymphoid Neoplasm with Eosinophilia and PCM1::JAK2 rearrangement representing as B-cell acute lymphoblastic leukemia B-ALL. | Ann Hematol | 2026 | 41530508 | PubTator, text mining | PubMed |
| Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapies. | Blood | 2026 | 41490267 | PubTator, text mining | PubMed |
| Comparative Analysis of 12 Flow Cytometry-Based Markers in B-Lymphoblastic Leukemia/Lymphoma and Their Utility in Detecting Minimal/Measurable Residual Disease. | Int J Lab Hematol | 2026 | 41466451 | PubTator, text mining | PubMed |
| A Novel CD58 Mutation-Related Signature Predicts Prognosis Risk in Diffuse Large B-Cell Lymphoma Patients. | Cancer Res Treat | 2026 | 40744814 | PubTator, text mining | PubMed |
| Biomarker understanding first lessons from drug development for IgA-driven autoimmune and fibrotic diseases. | Camb Prism Precis Med | 2025 | 41727309 | PubTator, text mining | PubMed |
| EVOLVE platform, a trispecific T cell engager with integrated CD2 costimulation, for the treatment of solid and hematologic tumors. | Proc Natl Acad Sci U S A | 2025 | 41252152 | PubTator, text mining | PubMed |
| Blood diagnostic biomarkers for neurologic manifestations of long COVID. | Brain Behav Immun Health | 2025 | 41146907 | PubTator, text mining | PubMed |
| Global DNA methylation signatures associated with chemoresistance and poor prognosis of high grade serous ovarian cancer. | Sci Rep | 2025 | 41125735 | PubTator, text mining | PubMed |
| Iris pigment epithelial cysts in acute lymphoblastic leukemia-a case report. | BMC Ophthalmol | 2025 | 41107744 | PubTator, text mining | PubMed |
| Systematic correlation analysis of human CD molecules reveals upregulated co-expression of CD58, CD63, and CD147 in patients with primary Sjögren's syndrome. | Immunol Res | 2025 | 41087625 | PubTator, text mining | PubMed |
| Pan-cancer and machine learning reveal the role of cell adhesion molecules in prognosis, immune remodeling, and anti-tumour therapy in lower-grade gliomas. | Discov Oncol | 2025 | 41066011 | PubTator, text mining | PubMed |
| CD2 and its ligands are involved in development and activation of MAIT cells. | J Exp Med | 2025 | 41026163 | PubTator, text mining | PubMed |
| Chemotherapy drugs do not affect the production of hepatitis B surface antibodies: A case report. | Oncol Lett | 2025 | 40995139 | PubTator, text mining | PubMed |
| IGH::IL3-Rearranged B-Cell Precursor Acute Lymphoblastic Leukemia With Hypereosinophilia in a Child With a Novel PAX5 Germline Variant. | Genes Chromosomes Cancer | 2025 | 40981401 | PubTator, text mining | PubMed |
| Pancreatic cancer cells escape T/NK cell immune surveillance through the expressional separation of CD58. | J Immunother Cancer | 2025 | 40953922 | PubTator, text mining | PubMed |
| Bacterial Vaginosis-Associated Prevotella timonensis Enhances Dendritic Cell-T Cell Clustering and Subsequent T Cell Proliferation. | Eur J Immunol | 2025 | 40899134 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/965/papers?page=3